{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:18:32Z","timestamp":1776172712278,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neurol.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T07:31:31Z","timestamp":1627457491000},"page":"760-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Medication overuse headache: Updating of the French recommendations regarding the treatment strategies"],"prefix":"10.1016","volume":"177","author":[{"given":"V.","family":"Corand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Moisset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Radat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurol.2021.07.003_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd edition","volume":"38","author":"Headache classification committee of the International Headache Society (IHS).","year":"2018","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.neurol.2021.07.003_bib0210","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","article-title":"Medication-overuse headache: risk factors, pathophysiology and management","volume":"12","author":"Diener","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2021.07.003_bib0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s10194-016-0649-2","article-title":"Headache, depression and anxiety: associations in the Eurolight project","volume":"17","author":"Lampl","year":"2016","journal-title":"J Headache Pain"},{"issue":"9995","key":"10.1016\/j.neurol.2021.07.003_bib0220","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2021.07.003_bib0225","doi-asserted-by":"crossref","DOI":"10.1007\/s10194-010-0217-0","article-title":"Prevalence of headache in Europe: a review for the Eurolight project","author":"Stovner","year":"2010","journal-title":"J Headache Pain"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.003_bib0230","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.003_bib0235","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","article-title":"Treatment of medication overuse headache\u2013guideline of the EFNS headache panel","volume":"18","author":"Evers","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2021.07.003_bib0240","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ene.14268","article-title":"European Academy of Neurology guideline on the management of medication-overuse headache","volume":"27","author":"Diener","year":"2020","journal-title":"European Journal Of Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2021.07.003_bib0245","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s00115-012-3680-9","article-title":"Therapy and care for patients with chronic migraine: Expert recommendations of the German Headache Society, German society of neurology, Austrian Headache society, Swiss headache Society","volume":"83","author":"Straube","year":"2012","journal-title":"Nervenartz"},{"key":"10.1016\/j.neurol.2021.07.003_bib0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nrl.2020.04.029","article-title":"Documento de revision y actualizacion de la cefalea por uso excesivo de medicacion (CUEM)","volume":"36","author":"Gonzalez-Oria","year":"2012","journal-title":"Neurologia"},{"key":"10.1016\/j.neurol.2021.07.003_bib0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-018-0921-8","article-title":"Guideline on the use of anabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation","volume":"19","author":"Bendtsen","year":"2018","journal-title":"The journal of Headache and Pain"},{"key":"10.1016\/j.neurol.2021.07.003_bib0260","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jpain.2016.12.005","article-title":"The effectiveness of treatments for patients with MOH: a systematic review and meta-analysis","volume":"6","author":"De Goffau","year":"2017","journal-title":"The Journal Of Pain"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.003_bib0265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2011.08.018","article-title":"Risk factors for\u00a0medication-overuse\u00a0headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag Health Studies","volume":"153","author":"Hagen","year":"2012","journal-title":"Pain."},{"issue":"10","key":"10.1016\/j.neurol.2021.07.003_bib0270","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/01.WNL.0000063322.14078.90","article-title":"Rates and predictors for relapse in medication overuse headache: a 1-year prospective study","volume":"60","author":"Katsarava","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurol.2021.07.003_bib0275","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1526-4610.2012.02191.x","article-title":"Treatment-resistant medication overuse headache can be cured","volume":"52","author":"Munksgaard","year":"2012","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.003_bib0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-1331.2010.03094.x","article-title":"Reduction in medication-overuse headache after short information. The Akershus study of chronic headache","volume":"18","author":"Grande","year":"2011","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.003_bib0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1468-2982.2009.01934.x","article-title":"Risk factors in medication overuse headache: a 1-year follow-up study (care II protocol)","volume":"30","author":"Sances","year":"2010","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.003_bib0290","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pain.2011.12.008","article-title":"Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache","volume":"153","author":"Lundqvist","year":"2012","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.neurol.2021.07.003_bib0295","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10194-012-0492-z","article-title":"Drug-dependence behavior and outcome of medication-overuse headache after treatment","volume":"13","author":"Corbelli","year":"2012","journal-title":"J Headache Pain"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.003_bib0300","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1468-2982.2007.01432.x","article-title":"Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up","volume":"27","author":"Zidverc-Trajkovic","year":"2007","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.003_bib0305","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0333102413515338","article-title":"Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)","volume":"34","author":"Bendtsen","year":"2013","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.003_bib0310","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/0333102411412088","article-title":"In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial","volume":"31","author":"Cr\u00e9ac\u2019h","year":"2011","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.003_bib0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1129-2377-14-10","article-title":"Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial","volume":"14","author":"Rossi","year":"2013","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.003_bib0320","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1468-1331.2010.03157.x","article-title":"Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache","volume":"18","author":"Rossi","year":"2011","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.003_bib0325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1468-2982.2008.01711.x","article-title":"Management of medication overuse headache: 1-year randomized multicenter open-label trial","volume":"29","author":"Hagen","year":"2009","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.neurol.2021.07.003_bib0330","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/ene.13318","article-title":"Lasting improvement of medication-overuse headache after brief intervention\u2013A long-term follow-up in primary care","volume":"24","author":"Kristoffersen","year":"2017","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.003_bib0335","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0333102415583146","article-title":"Detoxification in medication-overuse headache, a retrospective controlled follow-up study: does care by a headache nurse lead to cure?","volume":"36","author":"Pijpers","year":"2016","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.neurol.2021.07.003_bib0340","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/0333102416660549","article-title":"The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: a controlled multicenter study","volume":"37","author":"Tassorelli","year":"2017","journal-title":"Cephalalgia."},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2021.07.003_bib0345","first-page":"S117","article-title":"Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal","volume":"30","author":"Grazzi","year":"2009","journal-title":"NeurolSci"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.003_bib0350","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","article-title":"Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial","volume":"77","author":"Carlsen","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.003_bib0355","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.WNF.000022888.49044.99","article-title":"Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine","volume":"29","author":"Mei","year":"2006","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"10.1016\/j.neurol.2021.07.003_bib0360","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1468-2982.2009.01859.x","article-title":"Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse","volume":"29","author":"Diener","year":"2009","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.neurol.2021.07.003_bib0365","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.07.003_bib0370","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1468-2982.2009.01859.x","article-title":"Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse","volume":"29","author":"Diener","year":"2009","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.neurol.2021.07.003_bib0375","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.euroneuro.2014.03.010","article-title":"Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial","volume":"24","author":"Sarchielli","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2021.07.003_bib0380","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline","volume":"331","author":"Silberstein","year":"2013","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2021.07.003_bib0385","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10194-011-0339-z","article-title":"Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study","volume":"12","author":"Sandrini","year":"2011","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.003_bib0390","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1526-4610.2011.01990.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-Week PREEMPT clinical program","volume":"51","author":"Aurora","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.neurol.2021.07.003_bib0395","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa1709038","article-title":"Fremanezumab for the preventive treatment of chronic migraine","volume":"377","author":"Silberstein","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2021.07.003_bib0400","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(17)30083-2","article-title":"Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Tepper","year":"2017","journal-title":"Lancet Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721006147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721006147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:42:44Z","timestamp":1758519764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721006147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0035378721006147"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2021.07.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication overuse headache: Updating of the French recommendations regarding the treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}